Research presented at the Endocrine Society's 2025 annual meeting found that men on GLP-1 medications like semaglutide, who achieved a 10% weight reduction saw testosterone levels increase by 53% to 77% over 18 months
This comprehensive analysis, drawing on research published between 2000 and 2025, identifies key oxidative stress biomarkers, including malondialdehyde (MDA), 8-hydroxy-2-deoxyguanosine (8-OHdG), and total antioxidant capacity (TAC), as valuable tools for assessing sperm health and diagnosing oxidative imbalance
Factors such as BMI, overall health, and existing medical conditions will be considered to ensure safety and appropriateness
The study was deemed not to constitute research involving human subjects according to 45 Code of Federal Regulations 46.102(f) and deemed exempt from board oversight and from full review by the RTI International (Research Triangle Park, NC, US) institutional review board